Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage

NCT05382403
completednot_applicable

Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage

NCT02883673
completed

RUBY Post-Market Registry on the Jada® System

NCT04995887

Clinical Trials (3)

Showing 3 of 3 trials
NCT05382403Not Applicable

Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage

Recruiting
NCT02883673Not Applicable

Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage

Completed
NCT04995887

RUBY Post-Market Registry on the Jada® System

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3